Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
41.42
+0.44 (1.07%)
At close: Aug 1, 2025, 4:00 PM
41.16
-0.26 (-0.63%)
After-hours: Aug 1, 2025, 5:06 PM EDT
Guardant Health Analyst Ratings
Total Analysts
18
Consensus Rating
Strong Buy
Price Target
$55.67
Upside
+34.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +44.86% | Jul 31, 2025 |
| Raymond James | Raymond James | Buy Maintains $59 → $61 | Buy | Maintains | $59 → $61 | +47.27% | Jul 31, 2025 |
| Mizuho | Mizuho | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +56.93% | Jun 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $60 | Buy | Maintains | $50 → $60 | +44.86% | May 6, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $52 → $57 | Buy | Maintains | $52 → $57 | +37.61% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $60 → $65 | Strong Buy | Maintains | $60 → $65 | +56.93% | May 1, 2025 |
| Stifel | Stifel | Strong Buy Maintains $53 → $60 | Strong Buy | Maintains | $53 → $60 | +44.86% | May 1, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $60 | Buy | Maintains | $55 → $60 | +44.86% | May 1, 2025 |
| TD Securities | TD Securities | Strong Buy Maintains $56 → $60 | Strong Buy | Maintains | $56 → $60 | +44.86% | May 1, 2025 |
| UBS | UBS | Strong Buy Maintains $65 → $70 | Strong Buy | Maintains | $65 → $70 | +69.00% | May 1, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $55 | Buy | Maintains | $60 → $55 | +32.79% | Apr 10, 2025 |
| Mizuho | Mizuho | Buy Initiates $55 | Buy | Initiates | $55 | +32.79% | Apr 10, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $55 | Buy | Reiterates | $55 | +32.79% | Mar 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +25.54% | Mar 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $34 → $50 | Buy | Maintains | $34 → $50 | +20.71% | Feb 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +35.20% | Feb 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.